Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update

Abstract

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a highly pathogenic novel virus that has caused a massive pandemic called coronavirus disease 2019 (COVID-19) worldwide. Wuhan, a city in China became the epicenter of the outbreak of COVID-19 in December 2019. The disease was declared a pandemic globally by the World Health Organization (WHO) on 11 March 2020. SARS-CoV-2 is a beta CoV of the Coronaviridae family which usually causes respiratory symptoms that resemble common cold. Multiple countries have experienced multiple waves of the disease and scientific experts are consistently working to find answers to several unresolved questions, with the aim to find the most suitable ways to contain the virus. Furthermore, potential therapeutic strategies and vaccine development for COVID-19 management are also considered. Currently, substantial efforts have been made to develop successful and safe treatments and SARS-CoV-2 vaccines. Some vaccines, such as inactivated vaccines, nucleic acid-based, and vector-based vaccines, have entered phase 3 clinical trials. Additionally, diverse small molecule drugs, peptides and antibodies are being developed to treat COVID-19. We present here an overview of the virus interaction with the host and environment and anti-CoV therapeutic strategies; including vaccines and other methodologies, designed for prophylaxis and treatment of SARS-CoV-2 infection with the hope that this integrative analysis could help develop novel therapeutic approaches against COVID-19.

Antioxidant Activity of Citrus Limonoids and Investigation of Their Virucidal Potential against SARS-CoV-2 in Cellular Models

“…While pulmonary alterations are the main manifestation of the disease, systemic problems are also significantly present, with complications including acute cerebrovascular events, brain disorders and other systemic diseases [ 1 , 2 , 3 , 4 ]. Countries have globally made a lot of effort to counteract the epidemic via appropriate public health strategies, developing drugs and vaccines against SARS-CoV-2 [ 30 , 31 ].…”

What Happens to the Immune System after Vaccination or Recovery from COVID-19?

“…To generate this type of vaccine, the virus is cultivated in cells for amplification and inactivated with chemicals, UV light or heating. Thus, the entire inactivated virus provides a wide antigenic repertoire for the immune system, which hypothetically can be advantageous in the case of immune escape due to virus mutations [71,72]. CoronaVac (Sinovac Research and Development) and BBIBP-CorV (Sinopharm/China National Biotec Group Co/Beijing Institute of Biological Products) vaccines, both approved by the WHO, were based on SARS-CoV-2 inactivation.…”

Exploring the Psychological Stress, Anxiety Factors, and Coping Mechanisms of Critical Care Unit Nurses During the COVID-19 Outbreak in Saudi Arabia

“…Moreover, individuals were encouraged to implement social distancing to reduce the transmission of the infection (3). Taking this into consideration, there are no specific available drugs and vaccines for combating the infection during the first wave of this pandemic, and treatment relied on antiviral therapy, isolation, and symptomatic support in combination with a close monitoring of the progression of the disease (4,5), then the last year witnessed the development of vaccines for combating the pandemic (4)(5)(6)(7)(8)(9).…”